Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD
- PMID: 35366349
- DOI: 10.1002/hep.32504
Letter to the editor: Effect of diabetes medications and glycemic control on risk of HCC in patients with NAFLD
Comment on
-
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease.Hepatology. 2022 Jun;75(6):1420-1428. doi: 10.1002/hep.32244. Epub 2021 Dec 19. Hepatology. 2022. PMID: 34779535 Free PMC article.
References
REFERENCES
-
- Kramer JR, Natarajan Y, Dai J, Yu X, Li L, El-Serag HB, et al. Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. Hepatology. 2022;76:469-82https://doi.org/10.1002/hep.32244.
-
- Wu T, Kwok RM, Tran TT. Isolated anti-HBc: the relevance of hepatitis B core antibody-a review of new issues. Am J Gastroenterol. 2017;112(12):1780-8.
-
- Mak LY, Wong DK, Pollicino T, Raimondo G, Hollinger FB, Yuen MF. Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020;73(4):952-64.
-
- Ye W, Siwko S, Tsai RYL. Sex and race-related DNA methylation changes in hepatocellular carcinoma. Int J Mol Sci. 2021;22(8):3820.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
